During the past decade, Southeast Cancer Center conducted 177 clinical trials. In the 10-year time frame, 177 clinical trials started and 126 clinical trials were completed, i.e. on average, 71.2% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 82 clinical trials were completed. i.e. 115.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeast Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 120 trials, followed by "SWOG Cancer Research Network" with 67 trials sponsored, "Alliance for Clinical Trials in Oncology" with 54 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored and "Radiation Therapy Oncology Group" with 23 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 185 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Southeast Cancer Center" are "Breast Cancer" (19 trials), "Lung Cancer" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Colorectal Cancer" (9 trials). Many other conditions were trialed in "Southeast Cancer Center" in a lesser frequency.

Most popular intervention types in "Southeast Cancer Center" are "Drug" (241 trials), "Other" (164 trials), "Biological" (117 trials), "Procedure" (72 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (80 trials), "Quality-of-Life Assessment" (57 trials), "Questionnaire Administration" (40 trials), "Biospecimen Collection" (34 trials) and "Computed Tomography" (34 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Cancer Center" are 251 trials for "All" genders, 43 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Southeast Cancer Center". undefined are not yet recruiting, 71 are recruiting, 128 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 84 completed trials in Southeast Cancer Center, 6 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Cancer Center, 11 "Phase 1" clinical trials were conducted, 150 "Phase 2" clinical trials and 146 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".